Kimryn Rathmell, incoming director of the National Cancer Institute (Credit: Vanderbilt University)
November 17, 2023 12:57 PM ESTUpdated 01:50 PM
People
Pharma
FDA+

Biden taps Van­der­bilt’s Kim­ryn Rath­mell to suc­ceed Bertag­nol­li as the NI­H's can­cer chief

Lia DeGroot

Pres­i­dent Joe Biden se­lect­ed Van­der­bilt Uni­ver­si­ty’s med­i­cine chair Kim­ryn Rath­mell to serve as the next di­rec­tor of the Na­tion­al Can­cer In­sti­tute, the White House …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times